Expand IBB Menu
IBB MENU

ETF profile for iShares Biotechnology ETF (IBB) from the issuer: top holdings, net assets, expense ratio and shares outstanding.

IBB ETF Profile


Family: Blackrock (iShares)
Name: iShares Biotechnology ETF
Inception Date: 5-Feb-2001
Termination Date:
Investment Objective: The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector. It provides exposure to U.S. companies in the biotechnology industry.
Prospectus
Top 10 Holdings
GILEAD SCIENCES GILD 8.9607%
AMGEN INC AMGN 8.4830%
VERTEX PHARMACEUTICALS VRTX 7.7805%
REGENERON PHARMACEUTICALS REGN 6.5133%
MODERNA MRNA 5.8390%
ARGENX SE ADR ARGX 3.7671%
NATERA NTRA 3.0040%
BIOGEN BIIB 2.5379%
BEONE MEDICINES AG ONC 2.4173%
REVOLUTION MEDICINES RVMD 2.3488%
Top 10 Holdings Weight: 51.7%
Number of Holdings: 249
Shares Outstanding: 52,300,000
Total Net Assets: 11,408,721,920
NAV: 218.14
Net Expense Ratio: 0.44%
Asset Class: Equities (Stocks)
Developed or Emerging: Developed Market Funds
Country: US
Region:
Strategy:
Currency:
Commodity:
Sector: Healthcare
Industry: Biotech
Dividend Type:
Tax Exempt State:
Maturity Duration:
Market Cap: Large & Mid Cap
Credit Quality:
Mortgage Bond Types:
Bond Type:
Gov't Bond Types:
Reit Type:
Leverage Direction/Factor:
Is Currency Hedged: No
US or Ex-US: Domestic
Market Data Delayed 15 Minutes